Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - NBTY INC | a16-6182_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 11, 2016
NBTY, Inc.
(Exact name of registrant as specified in charter)
333-172973
(Commission File Number)
DELAWARE |
|
|
|
11-2228617 |
(State or other jurisdiction |
|
|
|
(I.R.S. Employer |
of incorporation) |
|
|
|
Identification No.) |
|
|
|
|
|
2100 Smithtown Avenue |
|
|
|
|
Ronkonkoma, New York |
|
|
|
11779 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
(631) 567-9500
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On March 11, 2016, NBTY, Inc. (the Company) announced the formation of a joint venture with By-Health Co., Ltd. in China. In connection with the formation of the joint venture, the Company will contribute certain intellectual property rights in exchange for a 40% interest in the joint venture. The joint venture is expected to commence operations during the second half of calendar year 2016, subject to certain customary closing conditions. A copy of the press release is furnished herewith as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
|
99.1 |
|
Press release dated March 11, 2016. |